Abstract:Aims: Restrictions during the COVID-19 crisis will have impacted on opportunities to be active. We aimed to (a) quantify the impact of COVID-19 restrictions on accelerometer-assessed physical activity and sleep in people with type 2 diabetes and (b) identify predictors of physical activity during COVID-19 restrictions. Methods: Participants were from the UK Chronotype of Patients with type 2 diabetes and Effect on Glycaemic Control (CODEC) observational study. Participants wore an accelerometer on their wrist … Show more
“…Overall, physical activity was lower in adults with type 2 diabetes during lockdown restrictions, particularly in women, older people, individuals with obesity, and minority ethnic populations. 106 Despite the expected negative impact of lockdown, retrospective analyses have not reported a worsening of glucose control due to lifestyle changes. 107 Current recommendations of metabolic disease management in a pandemic situation Encourage patients to restrict social contact to reduce risk of infection 97 Prioritise patients for vaccination 98 , 99 Encourage patients to incorporate a healthy lifestyle during lockdown and quarantine 22 Individual management: help patients to establish an individual set of self-management goals (eg, measurement rate, bodyweight, steps per day, waist circumference, blood pressure) and to adhere to these goals consistently 100 Digital support: help patients to make use of online education, virtual consultation, and digital health (eg, measurements of temperature, physical activity, bodyweight, waist circumference, and blood pressure, which will be digitally transferred to the physician) 101 Behavioural support: help patients to use digital stress management tools to increase resilience and stress resistance 102 Intensify foot care 103 Check for new diabetes 90 Manage cardiac risk 9 Encourage patients to adhere to lipid-lowering drugs 40 , 77 Monitor urinary excretion and oedema in patients with chronic kidney disease 12 Optimise metabolic and blood pressure control 101 Perform intensified glucose monitoring (eg, self-monitoring of blood glucose five times per day, flash and continuous glucose monitoring) to identify early deterioration of glycaemic condition and monitor blood pressure if hypertensive 101 Avoid grade 2 hypoglycaemia (2·2–3·0 mmol/L [40·0–55·0 mg/dL]) and grade 3 hypoglycaemia (1·7–2·2 mmol/L [30·0–40·0 mg/dL]) 104 Target ranges: 22 Fasting plasma glucose concentration: 4·0–8·0 mmol/L (72·0–144·0 mg/dL) Fasting plasma glucose concentration of patients in intensive care: 6·7–11·1 mmol/L (120·0–200·0 mg/dL) HbA 1c : <53·0 mmol/mol (7%) …”
Section: Implications For Medications and Therapymentioning
confidence: 99%
“…Overall, physical activity was lower in adults with type 2 diabetes during lockdown restrictions, particularly in women, older people, individuals with obesity, and minority ethnic populations. 106 Despite the expected negative impact of lockdown, retrospective analyses have not reported a worsening of glucose control due to lifestyle changes. 107 By contrast, it is evident that an endemic increase in excess weight and obesity in the global population, suggested to have caused more than a doubling of the number of people with type 2 diabetes over the past two decades, has now contributed to an excess of deaths due to COVID-19.…”
Section: Implications For Medications and Therapymentioning
Up to 50% of the people who have died from COVID-19 had metabolic and vascular disorders. Notably, there are many direct links between COVID-19 and the metabolic and endocrine systems. Thus, not only are patients with metabolic dysfunction (eg, obesity, hypertension, non-alcoholic fatty liver disease, and diabetes) at an increased risk of developing severe COVID-19 but also infection with SARS-CoV-2 might lead to new-onset diabetes or aggravation of pre-existing metabolic disorders. In this Review, we provide an update on the mechanisms of how metabolic and endocrine disorders might predispose patients to develop severe COVID-19. Additionally, we update the practical recommendations and management of patients with COVID-19 and post-pandemic. Furthermore, we summarise new treatment options for patients with both COVID-19 and diabetes, and highlight current challenges in clinical management.
“…Overall, physical activity was lower in adults with type 2 diabetes during lockdown restrictions, particularly in women, older people, individuals with obesity, and minority ethnic populations. 106 Despite the expected negative impact of lockdown, retrospective analyses have not reported a worsening of glucose control due to lifestyle changes. 107 Current recommendations of metabolic disease management in a pandemic situation Encourage patients to restrict social contact to reduce risk of infection 97 Prioritise patients for vaccination 98 , 99 Encourage patients to incorporate a healthy lifestyle during lockdown and quarantine 22 Individual management: help patients to establish an individual set of self-management goals (eg, measurement rate, bodyweight, steps per day, waist circumference, blood pressure) and to adhere to these goals consistently 100 Digital support: help patients to make use of online education, virtual consultation, and digital health (eg, measurements of temperature, physical activity, bodyweight, waist circumference, and blood pressure, which will be digitally transferred to the physician) 101 Behavioural support: help patients to use digital stress management tools to increase resilience and stress resistance 102 Intensify foot care 103 Check for new diabetes 90 Manage cardiac risk 9 Encourage patients to adhere to lipid-lowering drugs 40 , 77 Monitor urinary excretion and oedema in patients with chronic kidney disease 12 Optimise metabolic and blood pressure control 101 Perform intensified glucose monitoring (eg, self-monitoring of blood glucose five times per day, flash and continuous glucose monitoring) to identify early deterioration of glycaemic condition and monitor blood pressure if hypertensive 101 Avoid grade 2 hypoglycaemia (2·2–3·0 mmol/L [40·0–55·0 mg/dL]) and grade 3 hypoglycaemia (1·7–2·2 mmol/L [30·0–40·0 mg/dL]) 104 Target ranges: 22 Fasting plasma glucose concentration: 4·0–8·0 mmol/L (72·0–144·0 mg/dL) Fasting plasma glucose concentration of patients in intensive care: 6·7–11·1 mmol/L (120·0–200·0 mg/dL) HbA 1c : <53·0 mmol/mol (7%) …”
Section: Implications For Medications and Therapymentioning
confidence: 99%
“…Overall, physical activity was lower in adults with type 2 diabetes during lockdown restrictions, particularly in women, older people, individuals with obesity, and minority ethnic populations. 106 Despite the expected negative impact of lockdown, retrospective analyses have not reported a worsening of glucose control due to lifestyle changes. 107 By contrast, it is evident that an endemic increase in excess weight and obesity in the global population, suggested to have caused more than a doubling of the number of people with type 2 diabetes over the past two decades, has now contributed to an excess of deaths due to COVID-19.…”
Section: Implications For Medications and Therapymentioning
Up to 50% of the people who have died from COVID-19 had metabolic and vascular disorders. Notably, there are many direct links between COVID-19 and the metabolic and endocrine systems. Thus, not only are patients with metabolic dysfunction (eg, obesity, hypertension, non-alcoholic fatty liver disease, and diabetes) at an increased risk of developing severe COVID-19 but also infection with SARS-CoV-2 might lead to new-onset diabetes or aggravation of pre-existing metabolic disorders. In this Review, we provide an update on the mechanisms of how metabolic and endocrine disorders might predispose patients to develop severe COVID-19. Additionally, we update the practical recommendations and management of patients with COVID-19 and post-pandemic. Furthermore, we summarise new treatment options for patients with both COVID-19 and diabetes, and highlight current challenges in clinical management.
“…Lifestyle and health behavior including physical activity (PA) and dietary habits during the COVID-19 lockdown have been investigated [ 1 , 2 ]. The impact of the COVID-19 pandemic on dietary intake, PA, and sedentary behavior among different groups such as university students, elite para-athletes, community-dwelling older people, and patients with type 2 diabetes have been examined [ 1 , 3 , 4 , 5 ]. For instance, the COVID-19 state of emergency or lockdown has led to PA restrictions worldwide [ 6 ].…”
The COVID-19 pandemic has caused an abrupt change in lifestyle for many people with restrictions, often leading to a decrease in physical activity (PA), and thus contributing to a negative perception of health status. The purpose of this study was to examine the effects of the COVID-19 epidemic on physical activity and perceived physical fitness in Japanese adults aged 40 to 69 years. Data were collected from an online survey conducted between October 19 and 28, 2020. The analytic sample consisted of 1989 Japanese adults (mean age, 50.1 ± 6.9 years; women, 38.9%) who were aged between 40 and 69 years and completed the online survey. Overall, the PA time per week decreased by 32.4% between October 2019 and April 2020. A decrease in PA time was recorded in October 2020; however, a decline of 15.5% was observed. Compared to individuals who did not perceive a decline in physical fitness, individuals who perceived declining physical fitness during the COVID-19 state of emergency demonstrated a greater decrease in PA time in April 2020 (–50.5%), and this trend continued into October 2020 (–25.0%). These findings may indicate that Japanese adults aged 40 to 69 years who perceived declining physical fitness experienced a greater decrease in physical activity.
“…The COVID‐19 pandemic has reminded us of the ongoing physical inactivity pandemic that should not be ignored 8 . There is evidence of an unprecedented drop in physical activity during lockdown in the general population 9 and those with T2D 10 . We believe that physical activity will be focused on more than ever due to links between obesity and COVID‐19, 11 motivated by the UK Prime Minister's ‘war against fat’ 12 and will predominantly be looking to solve the negative fall outs from COVID‐19.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.